Market Overview:
The global immunoprotein diagnostic testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of autoimmune diseases, infectious diseases, and other chronic diseases. Additionally, the growing demand for early diagnosis and treatment of various diseases is also contributing to the growth of this market. Based on type, the global immunoprotein diagnostic testing market is segmented into c-reactive protein diagnostic test, complement system protein diagnostic test, prealbumin diagnostic test, haptoglobin diagnostic test, immunoglobulin (Ig) Diagnostic Test free light chain (FLC) Diagnostic Test and others. The c-reactive protein (CRP) diagnostics tests segment dominates this market owing to its high usage for early diagnosis and treatment monitoring across various applications such as autoimmune disease testing; infectious disease testing; allergytesting; endocrine testing; oncologytesting; toxicologytesting among others. Based on application type ,the global Immunoprotein diagnostics Testing Marketis dividedinto six segments: autoimmune Testing ;infectious DiseaseTesting ;allergyTesting ;endocrine Testing ;oncologyTestingand toxicologyTesting . Among these segments ,autoimmune Testing heldthe largest share in 2017and it is projectedto maintainits dominance duringthe forecast period .
Product Definition:
Immunoprotein diagnostic testing is a laboratory test that measures the levels of certain proteins in the blood. Immunoprotein diagnostic testing is used to diagnose and monitor diseases such as cancer, autoimmune disorders, and infections.
C-reactive Protein Diagnostic Test:
C-reactive protein diagnostic test is used for the diagnosis of chronic inflammation, which occurs when the body's immune system goes awry and starts to attack its own cells. The normal range for C-reactive protein levels in blood serum or plasma is 0.9 - 1.1 mg/L and it increases with age as well as due to certain diseases like rheumatoid arthritis, cancer, etc.
Complement System Protein Diagnostic Test:
Complement system protein diagnostic test is used for the detection of diseases related to complement system. The complement system plays an important role in the immune response by binding and neutralizing pathogens. This process is known as Complement activation or C3 activation. Activation of C3 leads to a series of biochemical and cellular events that help clear pathogens from the body, this process is calledcomplementary proteolysis or c3 peptidyl transferase activity.
Application Insights:
The application segment is divided into autoimmune testing, infectious disease testing, allergy testing, endocrine testing oncology toxicology and others. The infectious disease tests segment held the largest share in 2017 due to the increasing prevalence of chronic diseases such as HIV/AIDS and tuberculosis. An increase in these diseases has led to an increased demand for effective diagnostic tests that are sensitive and specific.
The autoimmune test segment is expected to witness lucrative growth over the forecast period owing to an increase in incidence of rheumatoid arthritis, Crohn¢â‚¬â„¢s disease and ulcerative colitis among other auto-immune disorders. Moreover, a rise in cancer cases across several organs including brain & spinal cord as well as lungs also contributes towards market growth during the forecast period (2018-2030). Increasing number of patients suffering from chronic conditions who are candidates for kidney transplantation also boosts product demand during this period (18-2030).
Regional Analysis:
North America dominated the global immunoprotein diagnostic testing market in 2017. This is due to the presence of well-established healthcare infrastructure, high adoption rate of advanced diagnostics techniques and rising prevalence of chronic diseases in this region. Moreover, increasing government initiatives for ImmunoProteomics studies are also expected to drive the demand for these tests over the forecast period. For instance, The National Institute of Health (NIH) has launched a Proteomics Research Project that focuses on discovery approaches using mass spectrometry and protein identification algorithms with application in disease diagnosis & drug development (PRIDE).
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to unmet clinical needs coupled with rapidly improving healthcare infrastructure & reimbursement policies across emerging countries such as China and India.
Growth Factors:
- Increasing incidence of autoimmune diseases: The global incidence of autoimmune diseases is increasing at a rapid pace. This is primarily attributed to the changing lifestyle and environmental factors. Immunoprotein diagnostic testing helps in early diagnosis and treatment of these diseases, thereby aiding in their management.
- Growing demand for personalized medicine: There is a growing demand for personalized medicine across the globe due to the increasing prevalence of complex diseases. Immunoprotein diagnostic testing helps in tailoring the treatment according to the individual’s needs, thus enhancing its efficacy.
- Technological advancements: The immunoprotein diagnostic testing market is witnessing significant technological advancements, which are helping in improving the accuracy and efficiency of tests performed on patients’ samples. This is resulting in increased adoption of these tests by healthcare providers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Immunoprotein Diagnostic Testing Market Research Report
By Type
C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Prealbumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, Free Light Chain Diagnostic Test, Others
By Application
Autoimmune Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, Toxicology Testing, Others
By Companies
Beckman Coulter, DiaSorin, F. Hoffmann-La Roche, Siemens Healthineers
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
215
Number of Tables & Figures
151
Customization Available
Yes, the report can be customized as per your need.
Global Immunoprotein Diagnostic Testing Market Report Segments:
The global Immunoprotein Diagnostic Testing market is segmented on the basis of:
Types
C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Prealbumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobulin Diagnostic Test, Free Light Chain Diagnostic Test, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Autoimmune Testing, Infectious Disease Testing, Allergy Testing, Endocrine Testing, Oncology Testing, Toxicology Testing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beckman Coulter
- DiaSorin
- F. Hoffmann-La Roche
- Siemens Healthineers
Highlights of The Immunoprotein Diagnostic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- C-reactive Protein Diagnostic Test
- Complement System Protein Diagnostic Test
- Prealbumin Diagnostic Test
- Haptoglobin Diagnostic Test
- Immunoglobulin Diagnostic Test
- Free Light Chain Diagnostic Test
- Others
- By Application:
- Autoimmune Testing
- Infectious Disease Testing
- Allergy Testing
- Endocrine Testing
- Oncology Testing
- Toxicology Testing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Immunoprotein Diagnostic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Immunoprotein diagnostic testing is a type of laboratory test that uses antibodies to identify specific proteins in the blood. Immunoprotein tests can be used to diagnose various diseases, including cancer.
Some of the major companies in the immunoprotein diagnostic testing market are Beckman Coulter, DiaSorin, F. Hoffmann-La Roche, Siemens Healthineers.
The immunoprotein diagnostic testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunoprotein Diagnostic Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Immunoprotein Diagnostic Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Immunoprotein Diagnostic Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Immunoprotein Diagnostic Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Immunoprotein Diagnostic Testing Market Size & Forecast, 2018-2028
4.5.1 Immunoprotein Diagnostic Testing Market Size and Y-o-Y Growth
4.5.2 Immunoprotein Diagnostic Testing Market Absolute $ Opportunity
Chapter 5 Global Immunoprotein Diagnostic Testing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Immunoprotein Diagnostic Testing Market Size Forecast by Type
5.2.1 C-reactive Protein Diagnostic Test
5.2.2 Complement System Protein Diagnostic Test
5.2.3 Prealbumin Diagnostic Test
5.2.4 Haptoglobin Diagnostic Test
5.2.5 Immunoglobulin Diagnostic Test
5.2.6 Free Light Chain Diagnostic Test
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Immunoprotein Diagnostic Testing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Immunoprotein Diagnostic Testing Market Size Forecast by Applications
6.2.1 Autoimmune Testing
6.2.2 Infectious Disease Testing
6.2.3 Allergy Testing
6.2.4 Endocrine Testing
6.2.5 Oncology Testing
6.2.6 Toxicology Testing
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Immunoprotein Diagnostic Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Immunoprotein Diagnostic Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Immunoprotein Diagnostic Testing Analysis and Forecast
9.1 Introduction
9.2 North America Immunoprotein Diagnostic Testing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Immunoprotein Diagnostic Testing Market Size Forecast by Type
9.6.1 C-reactive Protein Diagnostic Test
9.6.2 Complement System Protein Diagnostic Test
9.6.3 Prealbumin Diagnostic Test
9.6.4 Haptoglobin Diagnostic Test
9.6.5 Immunoglobulin Diagnostic Test
9.6.6 Free Light Chain Diagnostic Test
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Immunoprotein Diagnostic Testing Market Size Forecast by Applications
9.10.1 Autoimmune Testing
9.10.2 Infectious Disease Testing
9.10.3 Allergy Testing
9.10.4 Endocrine Testing
9.10.5 Oncology Testing
9.10.6 Toxicology Testing
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Immunoprotein Diagnostic Testing Analysis and Forecast
10.1 Introduction
10.2 Europe Immunoprotein Diagnostic Testing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Immunoprotein Diagnostic Testing Market Size Forecast by Type
10.6.1 C-reactive Protein Diagnostic Test
10.6.2 Complement System Protein Diagnostic Test
10.6.3 Prealbumin Diagnostic Test
10.6.4 Haptoglobin Diagnostic Test
10.6.5 Immunoglobulin Diagnostic Test
10.6.6 Free Light Chain Diagnostic Test
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Immunoprotein Diagnostic Testing Market Size Forecast by Applications
10.10.1 Autoimmune Testing
10.10.2 Infectious Disease Testing
10.10.3 Allergy Testing
10.10.4 Endocrine Testing
10.10.5 Oncology Testing
10.10.6 Toxicology Testing
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Immunoprotein Diagnostic Testing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Immunoprotein Diagnostic Testing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Immunoprotein Diagnostic Testing Market Size Forecast by Type
11.6.1 C-reactive Protein Diagnostic Test
11.6.2 Complement System Protein Diagnostic Test
11.6.3 Prealbumin Diagnostic Test
11.6.4 Haptoglobin Diagnostic Test
11.6.5 Immunoglobulin Diagnostic Test
11.6.6 Free Light Chain Diagnostic Test
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Immunoprotein Diagnostic Testing Market Size Forecast by Applications
11.10.1 Autoimmune Testing
11.10.2 Infectious Disease Testing
11.10.3 Allergy Testing
11.10.4 Endocrine Testing
11.10.5 Oncology Testing
11.10.6 Toxicology Testing
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Immunoprotein Diagnostic Testing Analysis and Forecast
12.1 Introduction
12.2 Latin America Immunoprotein Diagnostic Testing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Immunoprotein Diagnostic Testing Market Size Forecast by Type
12.6.1 C-reactive Protein Diagnostic Test
12.6.2 Complement System Protein Diagnostic Test
12.6.3 Prealbumin Diagnostic Test
12.6.4 Haptoglobin Diagnostic Test
12.6.5 Immunoglobulin Diagnostic Test
12.6.6 Free Light Chain Diagnostic Test
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Immunoprotein Diagnostic Testing Market Size Forecast by Applications
12.10.1 Autoimmune Testing
12.10.2 Infectious Disease Testing
12.10.3 Allergy Testing
12.10.4 Endocrine Testing
12.10.5 Oncology Testing
12.10.6 Toxicology Testing
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Immunoprotein Diagnostic Testing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Immunoprotein Diagnostic Testing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Immunoprotein Diagnostic Testing Market Size Forecast by Type
13.6.1 C-reactive Protein Diagnostic Test
13.6.2 Complement System Protein Diagnostic Test
13.6.3 Prealbumin Diagnostic Test
13.6.4 Haptoglobin Diagnostic Test
13.6.5 Immunoglobulin Diagnostic Test
13.6.6 Free Light Chain Diagnostic Test
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Immunoprotein Diagnostic Testing Market Size Forecast by Applications
13.10.1 Autoimmune Testing
13.10.2 Infectious Disease Testing
13.10.3 Allergy Testing
13.10.4 Endocrine Testing
13.10.5 Oncology Testing
13.10.6 Toxicology Testing
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Immunoprotein Diagnostic Testing Market: Competitive Dashboard
14.2 Global Immunoprotein Diagnostic Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Beckman Coulter
14.3.2 DiaSorin
14.3.3 F. Hoffmann-La Roche
14.3.4 Siemens Healthineers
